Mani Subramanian

1.8k total citations
62 papers, 1.1k citations indexed

About

Mani Subramanian is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Mani Subramanian has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hepatology, 37 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Mani Subramanian's work include Hepatitis C virus research (35 papers), Liver Disease Diagnosis and Treatment (28 papers) and Hepatitis B Virus Studies (19 papers). Mani Subramanian is often cited by papers focused on Hepatitis C virus research (35 papers), Liver Disease Diagnosis and Treatment (28 papers) and Hepatitis B Virus Studies (19 papers). Mani Subramanian collaborates with scholars based in United States, Canada and Australia. Mani Subramanian's co-authors include John G. McHutchison, Hongmei Mo, Diana M. Brainard, Luisa M. Stamm, Evguenia S. Svarovskaia, Bandita Parhy, Stephen D. Shafran, Robert H. Hyland, Sergio Borgia and Charlotte Hedskog and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Mani Subramanian

58 papers receiving 1.1k citations

Peers

Mani Subramanian

EPIDE

HEPAT

VIROL

Carmen Gallegos Spain

Eric G. Meissner United States

Sarah Maylin France

Akito Nozaki Japan

E. Walter Germany

P. Ciccorossi Italy

Raquel Lorente Spain

María Cristina Navas Colombia

H. C. Thomas United Kingdom

Rosendo Jardí Spain

Carmen Gallegos Spain

Mani Subramanian

1.1k ×1.3

EPIDE

1.4k ×1.8

HEPAT

276 ×1.3

213 ×1.0

81 ×0.7

VIROL

Citations per year, relative to Mani Subramanian Mani Subramanian (= 1×) peers Carmen Gallegos

Countries citing papers authored by Mani Subramanian

Since Specialization

Citations

This map shows the geographic impact of Mani Subramanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mani Subramanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mani Subramanian more than expected).

Fields of papers citing papers by Mani Subramanian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mani Subramanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mani Subramanian. The network helps show where Mani Subramanian may publish in the future.

Co-authorship network of co-authors of Mani Subramanian

This figure shows the co-authorship network connecting the top 25 collaborators of Mani Subramanian. A scholar is included among the top collaborators of Mani Subramanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mani Subramanian. Mani Subramanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vijayakumar, Archana, et al.. (2024). 1637-P: TLC-6740, a Liver-Targeted Mitochondrial Protonophore, Increases Energy Expenditure and Lipid Utilization in Obese Mice. Diabetes. 73(Supplement_1). 1 indexed citations

Podlaha, Ondřej, Edward Gane, Maurizia Rossana Brunetto, et al.. (2019). Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients. Scientific Reports. 9(1). 10529–10529. 15 indexed citations

Lawitz, Eric, Edward Gane, Peter Ruane, et al.. (2019). SAT-352-A combination of the ACC inhibitor GS-0976 and the nonsteroidal FXR agonist GS-9674 improves hepatic steatosis, biochemistry, and stiffness in patients with non-alcoholic steatohepatitis. Journal of Hepatology. 70(1). e794–e794. 9 indexed citations

Podlaha, Ondřej, George Y. Wu, Bryan Downie, et al.. (2019). Genomic modeling of hepatitis B virus integration frequency in the human genome. PLoS ONE. 14(7). e0220376–e0220376. 36 indexed citations

Younossi, Zobair M., Maria Stepanova, Eric Lawitz, et al.. (2018). Improvement of hepatic fibrosis and patient‐reported outcomes in non‐alcoholic steatohepatitis treated with selonsertib. Liver International. 38(10). 1849–1859. 74 indexed citations

Gane, Edward, Hyung Joon Kim, Kumar Visvanathan, et al.. (2018). Safety, Pharmacokinetics and Pharmacodynamics of Oral TLR8 Agonist GS-9688 in Patients with Chronic Hepatitis B: A Randomized, Placebo-Controlled, Double-Blind Phase 1b Study. Hepatology. 68. 2 indexed citations

Santana, Jorge, Juergen Rockstroh, Massimo Puoti, et al.. (2015). O322: Sofosbuvir and ribavirin therapy for the treatment of HIV/HCV co-infected patients with HCV GT1-4 infection: the PHOTON-1 and -2 Trials. Journal of the International AIDS Society. 18(3 (Suppl 2)).

Rosenberg, Gillian, Julianne Bayliss, Anuj Gaggar, et al.. (2014). P653 RECLASSIFICATION OF IMMUNOTOLERANT CHRONIC HEPATITIS B INFECTION; DETECTION OF HBV VARIANTS WITH IMPLICATIONS FOR HBV DNA, HBsAg AND HBeAg LEVELS. Journal of Hepatology. 60(1). S286–S286. 1 indexed citations

Meissner, Eric G., Y.-J. Lee, Anu Osinusi, et al.. (2014). Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients. Hepatology. 61(3). 790–801. 118 indexed citations

10.

Wyles, David, M. Rodríguez‐Torres, Eric Lawitz, et al.. (2014). All-Oral Combination of Ledipasvir, Vedroprevir, Tegobuvir, and Ribavirin in Treatment-Naïve Patients With Genotype 1 HCV Infection. Hepatology. 60(1). 56–64. 38 indexed citations

11.

Chan, Henry Lik‐Yuen, Marı́a Buti, Patrick Marcellin, et al.. (2013). 761 COMPARISON OF SERUM HBsAg DECLINES DURING TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN DIFFERENT CHRONIC HEPATITIS B (CHB) SUB-POPULATIONS. Journal of Hepatology. 58. S309–S310. 2 indexed citations

12.

Gane, Edward, Éric Sicard, Stuart C. Gordon, et al.. (2013). Safety and Pharmacodynamics of Oral TLR-7 agonist GS-9620 in patients with Chronic Hepatitis B. Hepatology. 58. 4 indexed citations

13.

Clark, Paul J., Alexander Thompson, David M. Vock, et al.. (2012). Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner. Hepatology. 56(1). 49–56. 66 indexed citations

14.

Subramanian, Mani, et al.. (2010). Prolapse of uterus and abdominal viscera with vaginal tear in a buffalo.. 31(2). 1 indexed citations

15.

Zeuzem, Stefan, Mark Sulkowski, E. Läwitz, et al.. (2009). 1041 EFFICACY AND SAFETY OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN TREATMENT- NAIVE, CHRONIC HEPATITIS C GENOTYPE 1 (CHC G1) PATIENTS. Journal of Hepatology. 50. S377–S377. 13 indexed citations

16.

Sood, Richa, et al.. (2008). Genomic detection of @vine herpesvims-2 in South Indian sheep and goat. The Indian Journal of Animal Sciences. 78(1). 1 indexed citations

17.

Bain, Vincent G., K. Kaita, Eric M. Yoshida, et al.. (2007). [9] COMPARABLE ANTIVIRAL RESPONSE RATES WITH ALBUMIN INTERFERON ALFA-2B DOSED AT Q2W OR Q4W INTERVALS IN NAIVE SUBJECTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C. Journal of Hepatology. 46. S7–S7. 3 indexed citations

18.

Li, Yan, Xizhong Cui, Xuemei Li, et al.. (2007). Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model*. Critical Care Medicine. 35(6). 1560–1567. 18 indexed citations

19.

Cui, Xizhong, Yan Li, Xuemei Li, et al.. (2007). Bacillus anthracisEdema and Lethal Toxin Have Different Hemodynamic Effects but Function Together to Worsen Shock and Outcome in a Rat Model. The Journal of Infectious Diseases. 195(4). 572–580. 50 indexed citations

20.

Hanley, Kathleen, Long Nguyen, Gregory P. Pogue, et al.. (2003). Development of a Plant Viral-Vector-Based Gene Expression Assay for the Screening of Yeast Cytochrome P450 Monooxygenases. Assay and Drug Development Technologies. 1(2). 147–160. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact